ALLE vs EXAS · P/E 21, rev $2.19B vs rev $2.76B
Allegion PLC (ALLE) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Allegion PLC (ALLE) is a security & protection services company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported ALLE revenue for 2026-06-30 was $2.19B. Net income was $322.7M. ALLE currently screens at market cap $12.71B and trailing P/E 20.7.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
ALLE currently screens at market cap $12.71B and trailing P/E 20.7. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the ALLE and EXAS stock pages for the full models.
Not investment advice.